MedPath
NMPA Approval

Ranitidine Hydrochloride Capsules

国药准字H61020938

August 12, 2019

Drug Information

盐酸雷尼替丁胶囊

胶囊剂

0.15g(按C13H22N403S计)

化学药品

August 12, 2019

Company Information

Applicant Company

陕西省汉中市城固县三合循环经济产业园区管理委员会

Manufacturing Company

四川双流西南航空港经济开发区空港二路361号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁胶囊 - NMPA 批准文号 | MedPath